Extendicare Inc. (OTCMKTS:EXETF – Get Free Report) crossed above its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of $20.47 and traded as high as $20.97. Extendicare shares last traded at $20.97, with a volume of 52,511 shares changing hands.
Analyst Ratings Changes
EXETF has been the topic of several recent research reports. Royal Bank Of Canada reissued an “outperform” rating on shares of Extendicare in a report on Friday, August 14th. Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of Extendicare in a report on Monday, October 26th. Five equities research analysts have rated the stock with a Buy rating. According to data from MarketBeat, the company currently has an average rating of “Buy”.
View Our Latest Stock Report on Extendicare
Extendicare Trading Up 4.0%
The stock’s fifty day simple moving average is $20.47 and its two-hundred day simple moving average is $21.66.
About Extendicare
Extendicare Inc. is a Canadian provider of continuing health care and senior living services. The company operates long-term care homes and retirement communities, serving older adults who require residential care, assistance with daily living, or supportive housing. Through its ParaMed business, Extendicare also provides home health-care services, including nursing, personal support, rehabilitation, and other care delivered in patients’ homes. In addition, the company offers management and consulting services to health-care and senior living operators through its Extendicare Assist platform.
Featured Articles
- Five stocks we like better than Extendicare
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
